We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilent Receives Expanded FDA Approval for Use of Companion Diagnostic in Identifying Gastric Cancer

Product News   Sep 25, 2017

 
Agilent Receives Expanded FDA Approval for Use of Companion Diagnostic in Identifying Gastric Cancer

Image Credit: Agilent Technologies

FURTHER INFORMATION
 
 
 

Related Product News

Mid-size Lab Haematology Analyzer Has Large Lab Capabilities

Product News

Beckman Coulter has announced the commercial launch of its new DxH 690T hematology analyzer.

READ MORE

“One-Stop Metabolite Shop” For Pharmaceutical and Agrochemical Research and Development

Product News

Hypha Discovery has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwide.

READ MORE

Clinical Trial for Validation of Point-of-care COPD Exacerbation Alert System Launches

Product News

A new clinical trial, COPE-WEL, aims to validate the Headstart® test for early detection and monitoring of pulmonary exacerbation of COPD.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE